Investing Experience Intermediate
Risk Profile Moderate
I am a retiree.
Followers
0
Following
0
Blog Posts
0
Threads
1,269
Blogs
Threads
Portfolio
Follower
Following
Summary
Total comments
1,269
Past 30 days
0
Past 7 days
0
Today
0
User Comments
Stock
Stock
2020-11-16 22:26 | Report Abuse
ally add me to yr private group...tks
Stock
Stock
Stock
Stock
Stock
Stock
2020-11-09 20:25 | Report Abuse
No infections among 56,000 people who traveled abroad after receiving Sinopharm-developed COVID-19 vaccine: developer
Global Times13:32 Nov 07 2020

vaccine Photo:VCG
None of the 56,000 people who were inoculated with a COVID-19 vaccine and travelled abroad have contracted the coronavirus, Sinopharm's chairman said on Friday.
Sinopharm Chairman Liu Jingzhen, said at a conference on Friday that some 100,000 people have been vaccinated with the company's vaccine and have shown none adverse reactions so far. Among those who were inoculated and travelled aboard, none have been infected with the virus, said Liu.
Some of those other received the emergency-use vaccine are employees of China National Petroleum Corporation, China Petrochemical Corporation and Technology giant Huawei.
Liu said that there are 99 people in Huawei's Mexico office, and 81 were vaccinated. Ten unvaccinated employees contracted with the virus in an outbreak in this office.
The fact that no one who received the vaccine has been infected, serves as more anecdotal evidence that the vaccine is working, Tao Lina, a Shanghai-based vaccine expert told the Global Times.
The data signals Sinopharm vaccine maybe close to being released on the market, Tao predicted.
Liu said that since June, Sinopharm's phase three clinic trial in dozens of countries and regions, including the UAE, Egypt, Bahrain, Peru and Morocco have more than 50,000 participants.
The results have moved the UAE ,Bahrain and other countries to approve urgent use of the Sinopharm vaccine, according to Liu, who told the conferred that he is "still alive and kicking, with no adverse reaction," after he was vaccinated in March.
Liu said the examples and scientific data prove the effectiveness of the company's COVID-19 vaccine.
Liu said Sinopharm is to produce about 100 million doses of vaccine by the end of the year, and estimates it will make 1 billion doses next year, to guarantee supplies especially for use by Chinese people, said Liu.
China has approved three vaccines for urgent use. Their vaccines have been given to high-risk groups, such as medical staff, diplomats sent to most-affected countries, and employees sent overseas under the Belt and Road Initiative.
These people have stayed abroad several months after being vaccinated, Zhou Song, general counsel CNBG, a Sinopharm subsidy said in September, according to the WeChat account of the State-owned Assets Supervision and Administration Commission of the State Council.
Global Times
Stock
2020-11-09 20:23 | Report Abuse
No infections among 56,000 people who traveled abroad after receiving Sinopharm-developed COVID-19 vaccine: developer
Global Times13:32 Nov 07 2020

vaccine Photo:VCG
None of the 56,000 people who were inoculated with a COVID-19 vaccine and travelled abroad have contracted the coronavirus, Sinopharm's chairman said on Friday.
Sinopharm Chairman Liu Jingzhen, said at a conference on Friday that some 100,000 people have been vaccinated with the company's vaccine and have shown none adverse reactions so far. Among those who were inoculated and travelled aboard, none have been infected with the virus, said Liu.
Some of those other received the emergency-use vaccine are employees of China National Petroleum Corporation, China Petrochemical Corporation and Technology giant Huawei.
Liu said that there are 99 people in Huawei's Mexico office, and 81 were vaccinated. Ten unvaccinated employees contracted with the virus in an outbreak in this office.
The fact that no one who received the vaccine has been infected, serves as more anecdotal evidence that the vaccine is working, Tao Lina, a Shanghai-based vaccine expert told the Global Times.
The data signals Sinopharm vaccine maybe close to being released on the market, Tao predicted.
Liu said that since June, Sinopharm's phase three clinic trial in dozens of countries and regions, including the UAE, Egypt, Bahrain, Peru and Morocco have more than 50,000 participants.
The results have moved the UAE ,Bahrain and other countries to approve urgent use of the Sinopharm vaccine, according to Liu, who told the conferred that he is "still alive and kicking, with no adverse reaction," after he was vaccinated in March.
Liu said the examples and scientific data prove the effectiveness of the company's COVID-19 vaccine.
Liu said Sinopharm is to produce about 100 million doses of vaccine by the end of the year, and estimates it will make 1 billion doses next year, to guarantee supplies especially for use by Chinese people, said Liu.
China has approved three vaccines for urgent use. Their vaccines have been given to high-risk groups, such as medical staff, diplomats sent to most-affected countries, and employees sent overseas under the Belt and Road Initiative.
These people have stayed abroad several months after being vaccinated, Zhou Song, general counsel CNBG, a Sinopharm subsidy said in September, according to the WeChat account of the State-owned Assets Supervision and Administration Commission of the State Council.
Global Times
Stock
Stock
Stock
Stock
Stock
Stock
Stock
Stock
2020-10-13 11:46 | Report Abuse
in the meantime goreng airasia dulu
Stock
Stock
Stock
2020-10-12 14:57 | Report Abuse
No.mkt maker great news also no use...
Stock
Stock
Stock
2020-10-12 11:30 | Report Abuse
Naim will utilise RM117mil from the proceeds to par down the group’s bank borrowings, which stood at RM483.5mil as at Dec 31,2019. It will reward shareholders with a cash dividend payout of RM90mil, which works out to about 18 sen per share based on the company’s 500.74 million shares (net of 13.06 million treasury shares).
Stock
Stock
Stock
2020-10-08 11:41 | Report Abuse
High volumn mayb bcos of esos ytday
Stock
Stock
2020-10-07 11:06 | Report Abuse
Lets wait n see can gap up pass 16.5 cts
Stock
2020-10-07 11:06 | Report Abuse
5mins goreng up the rest of day spent trapped retailers
Stock
2020-10-07 10:38 | Report Abuse
Whether alrdy reached climax ...nobody knows. Hopefully not many got trapped at high floor...
Stock
2020-10-07 10:37 | Report Abuse
It ends as soon as it started..within mins gap up to 16.5 then heavy selling fr then onwards...
Stock
2020-10-07 10:06 | Report Abuse
When everyone kmows it wont go up
Stock
2020-10-07 10:06 | Report Abuse
when ppl ask why...meaning no many know easier for mkt maker to push up
Stock
Stock
Stock
2020-10-06 11:58 | Report Abuse
Haiz not many ppl aware volumn stil so low
Stock
Stock
2020-10-06 10:45 | Report Abuse
Spill over to datasonic htpadu
Stock
2020-10-06 10:44 | Report Abuse
Ancomlb n iris vr stable today gap up
Stock
2020-10-06 10:43 | Report Abuse
If govnt to annouce it soon is stil not too late to buy
Stock
Stock
2020-10-06 10:37 | Report Abuse
Look at all the counters vying for Niis all GREEN today
iris dsonic htpadu my eg opcom
Stock
Stock
Stock
2020-09-30 16:55 | Report Abuse
Presbhd iris ancomlb actively traded all green ...could b sign of niis news...brewing
Stock
Stock
2020-09-30 16:31 | Report Abuse
not many sellers so.easy to push up
Stock
Stock
Stock: [INNATURE]: INNATURE BERHAD
2020-11-17 14:43 | Report Abuse
52cts coming